about
Interleukin-6 for diagnosis of sepsis in critically ill adult patientsOxidative-Nitrosative Stress and Myocardial Dysfunctions in Sepsis: Evidence from the Literature and Postmortem ObservationsSepsis-induced myocardial dysfunction: pathophysiology and managementIs It Time to Beta Block the Septic Patient?Mitochondrial Mechanisms in Septic CardiomyopathyCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsPathophysiology of sepsis-induced myocardial dysfunctionPlatelets and coagulation in infectionSepsis pathophysiology and anesthetic considerationCurrent concepts in the diagnosis and management of cytokine release syndrome.Pathologic function and therapeutic potential of exosomes in cardiovascular disease.Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathyLimitations of global end-diastolic volume index as a parameter of cardiac preload in the early phase of severe sepsis: a subgroup analysis of a multicenter, prospective observational study.Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activationSilencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions.Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial SepsisExcavatolide B Modulates the Electrophysiological Characteristics and Calcium Homeostasis of Atrial Myocytes.SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition.Puerarin attenuates the inflammatory response and apoptosis in LPS-stimulated cardiomyocytes.Long-Term Outcomes for Different Forms of Stress Cardiomyopathy After Surgical Treatment for Subarachnoid Hemorrhage.Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes.Clostridium Difficile Infection and Takotsubo Cardiomyopathy: Is There a Relation?Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice.The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsisEffects of echinocandin preparations on adult rat ventricular cardiomyocytes. Preliminary results of an in vitro studyLoss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis.3-Methylglutaconyl-Coenzyme-A Hydratase Deficiency and the Development of Dilated Cardiomyopathy.Takotsubo cardiomyopathy and acute infectious diseases: a mini-review of case reports.The synthetic antimicrobial peptide 19-2.5 attenuates mitochondrial dysfunction in cardiomyocytes stimulated with human sepsis serum.Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.Sepsis in Pediatric Cardiac Intensive Care.Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis.Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.A proposed role for sepsis in the pathogenesis of myocardial calcification.Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis.Myocardial depression induced by severe sepsis: successful rescue using extracorporeal cardiopulmonary resuscitation from initial phase of severe sepsis.PPAR-γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and NecroptosisCardiac effects of echinocandins after central venous administration in adult rats.Exosomes: new molecular targets of diseases.
P2860
Q24186689-B21F1233-DD91-4498-9A96-DB663FD597DFQ26747626-3F395B7B-FBFC-47B5-AF05-8F2B135A8C9BQ26751572-0BF7F41B-D375-40B9-B1FD-E885A2932A95Q26777818-CE1910D6-42AB-49AA-A080-D1388EA2A582Q26801508-40CB94BB-B576-492E-AA25-9372935624DBQ27026350-2C45203F-395F-4A30-8807-A66A99D7E563Q28079058-02DA9238-2353-40FC-AD1F-04080925FA23Q28079908-29553CE2-9C4D-4722-958B-115F3EF006B5Q28084129-F9D79EB5-7008-4B20-92D9-B79E0699DB81Q33886879-5A5A35E6-72E2-43FD-AFD3-EA2309203BE4Q34717025-8A1C2FB2-7FBC-4C77-BDD3-3953CE27A553Q34725636-7FFDEE2D-0768-4608-9E92-DA8F6507226CQ35107101-CAA44936-4BEE-40ED-A01A-A8F006219274Q35250425-D1B99C12-FCC2-4995-91E4-439534AA68EDQ35609951-5DB3F08A-35F8-488B-AB6D-D15A461576C8Q36035220-C3E9F050-7F4B-4A4B-A4B2-45C94335732FQ36260790-80D6C53A-68C4-49BA-91ED-4F10660452ECQ36460528-1BF3AF73-82A4-4B90-A9DA-4062E1C87F49Q36524467-781737D4-7BA2-47E9-9712-FD5E9AAF47E0Q36871149-96F45771-FECE-4A4B-8A7C-02FBC428BDE8Q36992085-B31EC7ED-D9BB-4265-A6DE-4300D2A297B4Q37028350-7E46443C-BD1E-4AC0-BA74-95D2CB7E3DD2Q37170256-9EC4E69A-11F4-4E5B-B8FA-D2F9B8B6717BQ37393972-835D8661-C7AC-4E53-A857-240CC0866665Q37419083-68A34CA0-5170-4141-82C2-3420CE5BD131Q37578555-B6C46F06-7C8F-4B57-8368-26ACE31A2402Q37647960-C26B1DD1-8485-46BA-9E68-93FD009360E2Q37711237-7640FDF3-2495-49BE-A01B-011F1A765FB8Q38191762-EDA9E44F-DBBB-47AE-9043-97C1199F283FQ38746473-7A4DC3B2-B1FE-4DC3-8216-E1547D38C19FQ38749984-300887AD-92A8-44FE-A67A-02264B6E2919Q38834618-2E5E0559-7041-4D7F-A25A-DB61F8999679Q38940783-56DD7995-803B-4A07-8A5A-0B48247912FBQ39493402-CD508370-9FBF-4694-B270-785DD682D3CDQ40151245-2A21C63B-342D-4AF3-86B2-47DB82556C2FQ40968439-4AA373A1-9EF8-4610-A7C0-C702D96A5483Q41110084-31031847-3056-40CF-ACB4-9244FA3A3CE1Q41440729-9D993AD1-FDB5-44A6-8A97-0CA043CC0045Q42111965-327C0921-64CE-4FE5-A90F-2993048A67B5Q47315747-DCD1418B-A861-4AC6-BC15-A0F55590A235
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sepsis-induced cardiomyopathy.
@ast
Sepsis-induced cardiomyopathy.
@en
type
label
Sepsis-induced cardiomyopathy.
@ast
Sepsis-induced cardiomyopathy.
@en
prefLabel
Sepsis-induced cardiomyopathy.
@ast
Sepsis-induced cardiomyopathy.
@en
P2093
P2860
P921
P1476
Sepsis-induced cardiomyopathy.
@en
P2093
Francisco J Romero-Bermejo
Julian Gil-Cebrian
Manuel Ruiz-Bailen
Maria J Huertos-Ranchal
P2860
P304
P356
10.2174/157340311798220494
P5008
P577
2011-08-01T00:00:00Z